MedLife’s net profit almost doubled RON123 million (up 93%).
“We currently have discussions in advanced stages for three large transactions and another five small ones and we aim to complete them by the end of this year. In fact, the investment budget planned for the next period is EUR100-120 million and we intend to allocate approximately EUR50-70 million for transactions in Romania and in the countries in the region,” said Mihai Marcu, President and CEO of MedLife Group.
MedLife’s clinics division contributed the largest share to the turnover, with more than RON400 million sales in 2021, an increase of RON100 million from the previous year. The hospital and laboratory business lines, too, had a significant contribution.
Last year’s investments reached EUR30 million, as the group strengthened its presence in several medical areas, such as radiotherapy and oncology.
Medlife SA, a company listed on the Bucharest Stock Exchange, has a capitalization of RON2.8 billion. Its main shareholders are Mihai Marcu, 15.4%, Mihaela Cristescu, 14%, Nicolae Marcu, 10.5%, and Fondul de Pensii NN (pension fund), 12.8%.
(English version by Loredana Fratila-Cristescu)